Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Anyfin (1)
Mandate

Vinge advises Anyfin

May 21, 2019 Capital Markets and Public M&A

Vinge has advised the fintech company Anyfin AB in connection with an investment round of approximately MSEK 80, in which new and existing investors are participating including, among others, Accel, Northzone, Global Founders Capital and Fintech Collective.

Anyfin helps its customers to reduce their interest costs by refinancing existing loans and giving better offers in respect of the customers’ loans.

Vinge’s team consisted of responsible partner Johan Larsson together with associates Filip Öhrner and Jesper Lindvall.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026